EUVIMEDEUVIMED entdecken
Systematische Übersicht

Clinical Characteristics of Malignant Phosphaturic Mesenchymal Tumor Causing Tumor-Induced Osteomalacia

Veronica Abate iD, Anita Vergatti iD, Gianpaolo De Filippo iD, Vincenzo Damiano, Ciro Menale, Lanfranco D'Elia iD, Domenico Rendina iD

The Journal of Clinical Endocrinology & Metabolism · 2024

DOI: 10.1210/clinem/dgad690 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Veronica Abate und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine and Surgery, University of Naples "Federico II", 80131 Naples, Italy. Hauptthemen laut MEDLINE: Osteomalacia, Neoplasms, Connective Tissue, Paraneoplastic Syndromes, Soft Tissue Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome usually caused by oversecretion of fibroblast growth factor 23 (FGF23) from a phosphaturic mesenchymal tumor (PMT). PMTs are usually benign neoplasms but some of them show malignant characteristics.

Objective

The aim of this study was to compare the clinical characteristics of benign and malignant PMTs inducing TIO.

Methods

On March 31, 2023, we performed a systematic review of individual patient data analysis in Medline, Google Scholar, Google book, and Cochrane Library using the terms “tumor induced osteomalacia,” “oncogenic osteomalacia,” “hypophosphatemia,” with no language restrictions and according to Preferred Reporting Items for Systematic reviews and Meta-Analyses criteria.

Results

Overall, we collected data from 837 patients with TIO in which the diagnosis of benign and malignant PMT was specified. Of them, 89 were affected by malignant PMT and 748 by benign PMT. Patients with malignant PMTs were younger and presented bone pain, functional impairment, and bone deformities more frequently. Malignant PMTs showed higher values of intact FGF23 and a higher mortality rate.

Conclusion

The study results identify the clinical characteristics of patients with malignant TIO, permitting the early identification of patients with PMT at increased risk of malignancy. This may significantly improve the diagnostic approach to disease. Further experimental studies are mandatory to clarify the role of FGF23 in the pathogenesis of malignancy in PMTs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteomalaciaNeoplasms, Connective TissueParaneoplastic SyndromesSoft Tissue NeoplasmsMesenchymomaHumansFibroblast Growth Factors

Stichwörter der Autor:innen

FGF23oncogenic osteomalaciaphosphaturic mesenchymal tumorstumor-induced osteomalacia

Substanzen

Fibroblast Growth Factors

Autor:innen und Institutionen

  • Department of Clinical Medicine and Surgery, University of Naples "Federico II", 80131 Naples, Italy.
  • Assistance Publique-Hôpitaux de Paris, Hôpital Robert-Debré, Service d'Endocrinologie-Diabétologie, 75019 Paris, France.
  • Clinical Department of Oncology and Hematology, University of Naples "Federico II", 80131 Naples, Italy.

ORCID-Profile: Veronica Abate, Anita Vergatti, Gianpaolo De Filippo, Lanfranco D'Elia, Domenico Rendina

Zitieren

APA

Abate, V., Vergatti, A., De Filippo, G., Damiano, V., Menale, C., D'Elia, L., & Rendina, D. (2024). Clinical Characteristics of Malignant Phosphaturic Mesenchymal Tumor Causing Tumor-Induced Osteomalacia. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad690

Vancouver

Abate V, Vergatti A, De Filippo G, Damiano V, Menale C, D'Elia L, et al. Clinical Characteristics of Malignant Phosphaturic Mesenchymal Tumor Causing Tumor-Induced Osteomalacia. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgad690

BibTeX
@article{Abate2024,
  author = {Abate, Veronica and Vergatti, Anita and De Filippo, Gianpaolo and Damiano, Vincenzo and Menale, Ciro and D'Elia, Lanfranco and Rendina, Domenico},
  title = {Clinical Characteristics of Malignant Phosphaturic Mesenchymal Tumor Causing Tumor-Induced Osteomalacia},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2024},
  doi = {10.1210/clinem/dgad690}
}
Kostenlos starten →